Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Rusthoven, James
  • Quirt, IC
  • Iscoe, NA
  • McCulloch, PB
  • James, KW
  • Lohmann, RC
  • Jensen, J
  • BurdetteRadoux, S
  • Bodurtha, AJ
  • Silver, HKB
  • Verma, S
  • Armitage, GR
  • Zee, B
  • Bennett, K
  • Hedley, D
  • Fine, S
  • Myers, R
  • King, M
  • Mertens, W
  • Taylor, M
  • Cano, P
  • Malik, S
  • Vergidis, D
  • Shore, S
  • Dudgeon, D
  • Smylie, M
  • Wilson, K
  • Knowling, M
  • Samosh, M
  • Giesbrecht, J
  • Huan, S
  • Skillings, J
  • Gregg, R
  • Belanger, K
  • Pollak, M
  • Latreille, J
  • Batist, G
  • Boos, G
  • Gruner, P
  • Hings, I
  • Loutfi, A
  • Thirlwell, M
  • Trudeau, M
  • Jolivit, J
  • Ayoub, J
  • Charpentier, D
  • Clement, S
  • Yelle, L
  • Belanger, D
  • Shibata, H

publication date

  • July 1, 1996